Diabetes, obesity & metabolism · 2026
Swimming With the Omnipod 5 Automated Insulin Delivery System: An Observational Investigation of Swimmers With Type 1 Diabetes in the Omnipod 5 Pivotal Trial.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zaharieva Dessi P, Kingman Ryan S, Lal Rayhan A, Nykaza Ed, Buckingham Bruce A, Hughes Michael S
Аннотация
AIMS: Limited studies have investigated glucose management around swimming in type 1 diabetes (T1D). This observational study of the Omnipod 5 Automated Insulin Delivery (AID) System assessed glycemic patterns and system operation with AID use during swimming.
MATERIALS AND METHODS: A total of seven swimmers (aged 11 ± 2 years, 57% female) with T1D recorded their swims using an activity tracker and completed online surveys after swims.
RESULTS: Participants reported 124 swims lasting 23-146 min. Median (IQR) starting glucose was 133 (93-178) mg/dL, with a change of -17 (-61 to 7) mg/dL during swims. Carbohydrate intake 2-h before swims was 20 (0-32) grams. Starting glucose ≥ 181 mg/dL showed the largest glucose decreases [-86 (-111 to -25) mg/dL] during swims. Activity feature was used in 87% of swims with a starting glucose < 90 mg/dL. Automated Mode was maintained for 98% (95%-100%) of swim time with 58% (24%-70%) of this time in Automated Mode: Limited.
CONCLUSIONS: Swimming with AID was associated with generally modest declines in glucose. The Omnipod 5 System largely preserved automation in water (often via Automated Mode: Limited) without reverting to Manual Mode. Starting glucose dominated glycemic trajectory, with larger declines but low hypoglycemia risk at a higher starting glucose, and smaller changes, but more hypoglycemia at a lower starting glucose. Insulin suspension was not enough to reliably prevent hypoglycemia when starting glucose was < 180 mg/dL, highlighting the need for proactive carbohydrate intake with a lower starting glucose, even with AID.
MATERIALS AND METHODS: A total of seven swimmers (aged 11 ± 2 years, 57% female) with T1D recorded their swims using an activity tracker and completed online surveys after swims.
RESULTS: Participants reported 124 swims lasting 23-146 min. Median (IQR) starting glucose was 133 (93-178) mg/dL, with a change of -17 (-61 to 7) mg/dL during swims. Carbohydrate intake 2-h before swims was 20 (0-32) grams. Starting glucose ≥ 181 mg/dL showed the largest glucose decreases [-86 (-111 to -25) mg/dL] during swims. Activity feature was used in 87% of swims with a starting glucose < 90 mg/dL. Automated Mode was maintained for 98% (95%-100%) of swim time with 58% (24%-70%) of this time in Automated Mode: Limited.
CONCLUSIONS: Swimming with AID was associated with generally modest declines in glucose. The Omnipod 5 System largely preserved automation in water (often via Automated Mode: Limited) without reverting to Manual Mode. Starting glucose dominated glycemic trajectory, with larger declines but low hypoglycemia risk at a higher starting glucose, and smaller changes, but more hypoglycemia at a lower starting glucose. Insulin suspension was not enough to reliably prevent hypoglycemia when starting glucose was < 180 mg/dL, highlighting the need for proactive carbohydrate intake with a lower starting glucose, even with AID.